Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes

References

• Mittenberg AG, Moiseeva TN, Barlev NA. Role of proteasomes in transcription and their regulation by covalent modifications. Front Biosci. 2008;13:7184–7192. PMID: 18508726.
   PubMed Web of Science ®Google Scholar
• Mittenberg AG. Non-canonical activities of proteasomes. Tsitologiia. 2014 in Russian;56:331–339. PMID: 25696972.
   PubMedGoogle Scholar
• Tsimokha AS, Kulichkova VA, Karpova EV, et al. DNA damage modulates interactions between microRNAs and the 26S proteasome. Oncotarget. 2014;5:3555–3567. PMID: 25004448.
   PubMed Web of Science ®Google Scholar
• Moiseeva TN, Bottrill A, Melino G, et al. DNA damage-induced ubiquitylation of proteasome controls its proteolytic activity. Oncotarget. 2013;4:1338–1348. PMID: 23907514.
   PubMedGoogle Scholar
• Baugh JM, Viktorova EG, Pilipenko EV. Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J Mol Biol. 2009;386:814–827. PMID: 19162040.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Matsufuji S, Kameji T, et al. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature. 1992;360:597–599. PMID: 1334232.
   PubMed Web of Science ®Google Scholar
• Tsvetkov P, Reuven N, Shaul Y. Ubiquitin-independent p53 proteasomal degradation. Cell Death Differ. 2010;17:103–108. PMID: 19557012.
   PubMed Web of Science ®Google Scholar
• Malatesta M, Peschiaroli A, Memmi EM, et al. The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity. Oncogene. 2013;32:4721–4726. PMID: 23085759.
   PubMed Web of Science ®Google Scholar
• Barlev NA, Sayan BS, Candi E, et al. The microRNA and p53 families join forces against cancer. Cell Death Differ. 2010;17:373–375. PMID: 20062068.
   PubMed Web of Science ®Google Scholar
• Cayrol C, Ducommun B. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene. 1998;17:2437–2444. PMID: 9824154.
   PubMed Web of Science ®Google Scholar
• Touitou R, Richardson J, Bose S, et al. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 α-subunit of the 20S proteasome. EMBO J. 2001;20:2367–2375. PMID: 11350925.
   PubMed Web of Science ®Google Scholar
• Sdek P, Ying H, Chang DLF, et al. MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell. 2005;20:699–708. PMID: 16337594.
   PubMed Web of Science ®Google Scholar
• Bae MH, Jeong CH, Kim SH, et al. Regulation of Egr-1 by association with the proteasome component C8. BBA. 2002;1592:163–167. PMID: 12379479.
   PubMed Web of Science ®Google Scholar
• Konstantinova IM, Tsimokha AS, Mittenberg AG. Role of proteasomes in cellular regulation. Int Rev Cell Mol Biol. 2008;267:59–124. PMID: 18544497.
   PubMed Web of Science ®Google Scholar
• Moiseeva TN, Mittenberg AG, Barlev NA. Proteasomes and their role in transcriptional regulation. Tsitologiia. 2010;52:195–203. in Russian. PMID: 20429296.
   PubMedGoogle Scholar
• Hideshima T, Richardson P, Chauhan D, et al. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human. Multiple Myeloma Cells Cancer Res. 2001;61:3071–3076. PMID: 11306489.
   Google Scholar
• Obeng EA, Carlson LM, Gutman DM, et al. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood. 2006;107:4907–4916. PMID: 16507771.
   PubMed Web of Science ®Google Scholar
• Hoyt MA, Coffino P. 5. ubiquitin-independent mechanisms of substrate recognition and degradation by the proteasome. Protein Degradation: the Ubiquitin-Proteasome System and Disease. 2007;4:107–121.
   Google Scholar
• Hwang J, Winkler L, Kalejta RF. Ubiquitin-independent proteasomal degradation during oncogenic viral infections. Biochim Biophys Acta. 2011;1816:147–157. PMID: 21664948.
   PubMed Web of Science ®Google Scholar
• Pickering AM, Davies KJ. Degradation of damaged proteins: the main function of the 20S proteasome. Prog Mol Biol Transl Sci. 2012;109:227–248. PMID: 22727423.
   PubMed Web of Science ®Google Scholar
• Van Der Lee R, Buljan M, Lang B, et al. Classification of intrinsically disordered regions and proteins. Chem Rev. 2014;114:6589–6631. PMID: 24773235.
   PubMed Web of Science ®Google Scholar
• Cilia E, Pancsa R, Tompa P, et al. From protein sequence to dynamics and disorder with dynamine. Nat Commun. 2013;4:2741. PMID: 24225580.
   PubMed Web of Science ®Google Scholar
• Cilia E, Pancsa R, Tompa P, et al. The dynamine webserver: predicting protein dynamics from sequence. Nucl Acids Res. 2014;42:W264–W270. PMID: 24728994.
   PubMed Web of Science ®Google Scholar
• Linding R, Russell RB, Neduva V, et al. GlobPlot: exploring protein sequences for globularity and disorder. Nucleic Acids Res. 2003;31:3701–3708. PMID: 12824398.
   PubMed Web of Science ®Google Scholar
• Walsh I, Martin AJ, Di Domenico T, et al. CSpritz: accurate prediction of protein disorder segments with annotation for homology, secondary structure and linear motifs. Nucleic Acids Res. 2011;39:W190–W196. PMID: 21646342.
   PubMed Web of Science ®Google Scholar
• Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol. 2002;3:195–205. PMID: 11994740.
   PubMed Web of Science ®Google Scholar
• Moumen A, Masterson P, O’Connor MJ, et al. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell. 2005;123:1065–1078. PMID: 16360036.
   PubMed Web of Science ®Google Scholar
• Ma WJ, Cheng S, Campbell C, et al. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem. 1996;271:8144–8151. PMID: 8626503.
   PubMed Web of Science ®Google Scholar
• Tran H, Maurer F, Nagamine Y. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol. 2003;23:7177–7188. PMID: 14517288.
   PubMed Web of Science ®Google Scholar
• Wang H, Zeng F, Liu Q, et al. The structure of the ARE-binding domains of hu antigen R (HuR) undergoes conformational changes during RNA binding. Acta Crystallographica Section D: Biological Crystallography. 2013;69:373–380. PMID: 23519412.
   PubMed Web of Science ®Google Scholar
• González-Feliciano JA, Hernández-Pérez M, Estrella LA, et al. The role of HuR in the post-transcriptional regulation of interleukin-3 in T cells. PLoS One. 2014;9(3):e92457. PMID: 24658545.
   PubMed Web of Science ®Google Scholar
• Grune T, Catalgol B, Licht A, et al. HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic Biol Med. 2011;51:1355–1364. PMID: 21767633.
   PubMed Web of Science ®Google Scholar
• Morozov AV, Astakhova TM, Garbuz DG, et al. Interplay between recombinant Hsp70 and proteasomes: proteasome activity modulation and ubiquitin-independent cleavage of Hsp70. Cell Stress Chaperones. 2017;22:687–697. PMID: 28447215.
   PubMed Web of Science ®Google Scholar
• Erales J, Coffino P. Ubiquitin-independent proteasomal degradation. PMID: 23684952 Biochim Biophys Acta. 2014;18431:216–221.
   PubMed Web of Science ®Google Scholar
• Jariel-Encontre I, Bossis G, Piechaczyk M. Ubiquitin-independent degradation of proteins by the proteasome. Biochim Biophys Acta - Reviews on Cancer. 2008;1786:153–177. PMID: 18558098.
   PubMed Web of Science ®Google Scholar
• Fedorova OA, Moiseeva TN, Nikiforov AA, et al. Proteomic analysis of the 20S proteasome (PSMA3)-interacting proteins reveals a functional link between the proteasome and mRNA metabolism. Biochem Biophys Res Commun. 2011;416:258–265. PMID: 22079093.
   PubMed Web of Science ®Google Scholar
• Chaudhury A, Chander P, Howe PH. Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: focus on hnRNP E1’s multifunctional regulatory roles. RNA. 2010;16:1449–1462. PMID: 20584894.
   PubMed Web of Science ®Google Scholar
• Yu C, Guo J, Liu Y, et al. Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation. J Cell Physiol. 2015;230:2252–2261. PMID: 25752295.
   PubMed Web of Science ®Google Scholar
• Barboro P, Ferrari N, Balbi C. Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression. Cancer Lett. 2014;352:152–159. PMID: 25016060.
   PubMed Web of Science ®Google Scholar
• Va K, Oa F, As T, et al. 26S proteasome exhibits endoribonuclease activity controlled by extra-cellular stimuli. Cell Cycle. 2010;9:840–849. PMID: 20139718.
   PubMed Web of Science ®Google Scholar
• Mittenberg AG, Moiseeva TN, Kuzyk VO, et al. Regulation of endoribonuclease activity of alpha-type proteasome subunits in proerythroleukemia K562 upon hemin-induced differentiation. Protein J. 2016;35:17–23. PMID: 26661102.
   PubMed Web of Science ®Google Scholar
• Shan Z, A S, Bodaghi S, et al. TUSC1, a putative tumor suppressor gene, reduces tumor cell growth in vitro and tumor growth in vivo. PLoS One. 2013;8:e66114. PMID: 23776618.
   PubMed Web of Science ®Google Scholar
• Kanda M, Shimizu D, Nomoto S, et al. Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer. J Surg Oncol. 2014;110:136–144. PMID: 24700496.
   PubMed Web of Science ®Google Scholar
• Shimizu D, Kanda M, Nomoto S, et al. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma. Oncol Rep. 2014;31:1305–1313. PMID: 24366000.
   PubMed Web of Science ®Google Scholar
• Guan M, Chen X, Ma Y, et al. MDA-9 and GRP78 as potential diagnostic biomarkers for early detection of melanoma metastasis. Tumour Biol. 2015;36:2973–2982. PMID: 25480418.
   PubMedGoogle Scholar
• Ramos FS, Serino LT, Carvalho CM, et al. PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer. Genet Mol Res. 2015;14:6960–6967. PMID: 26125904.
   PubMed Web of Science ®Google Scholar
• Shevtsov M, Huile G, Multhoff G. Membrane heat shock protein 70: a theranostic target for cancer therapy. Philos Trans R Soc Lond B Biol Sci. 2018;373(1738):20160526. pii.
   PubMedGoogle Scholar
• Guo S, Zou J, Wang G. Advances in the proteomic discovery of novel therapeutic targets in cancer. Drug Des Devel Ther. 2013;7:1259–1271. PMID: 24187485.
   PubMed Web of Science ®Google Scholar
• Matsuoka Y, Moore GE, Yagi Y, et al. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med. 1967;125:1246–1250. PMID: 6042436.
   PubMed Web of Science ®Google Scholar
• Mittenberg AG, Moiseeva TN, Barlev NA. Method of identifying the short-living regulatory proteins in human proteome involved in the specific modulation of cytotoxic effect. Inventions. Useful Models. Official Bulletin of Federal Service for Intellectual Property (Russia). 2016;19(2590700):1–12.
   Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227: 680–685. PMID: 5432063.
   PubMed Web of Science ®Google Scholar
• Fukuchi S, Amemiya T, Sakamoto S, et al. IDEAL in illustrates interaction networks composed of intrinsically disordered proteins and their binding partners. Nucleic Acids Res. 2014;42:D320–D325. PMID: 24178034.
   PubMed Web of Science ®Google Scholar
• Ben-Nissan G, Sharon M. Regulating the 20S proteasome ubiquitin-independent degradation pathway. Biomolecules. 2014;4:862–884. PMID: 25250704.
   PubMedGoogle Scholar